세계의 필라리아증 치료 시장 보고서(2025년)

Filariasis Treatment Global Market Report 2025

US $ 4,490 ￦ 6,319,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,134,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,949,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

필라리아증 치료 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 연간 평균 성장률(CAGR) 11.7%로 성장할 전망이며, 179억 1,000만 달러로 성장이 예측됩니다. 예측 기간 동안의 성장은 정부 프로그램, 헬스케어 솔루션에 대한 관심 고조, 헬스케어 시설 개선, 경구약 수요 고조, 유행 지역에서 필라리아증의 지속적인 유행 등의 요인에 기인할 것으로 보입니다. 이 기간 주요 동향으로는 3제 병용요법 도입, 보다 장시간 작용하는 항필라리아제 개발 연구 진행, CRISPR 및 분자생물학의 진보, 새로운 진단 도구 개발, 림프부종 관리 기술 향상 등을 들 수 있습니다.

상피병의 이환율 증가는 향후 수년간 필라리아증 치료 시장의 성장을 가속할 것으로 예측됩니다. 상피병은 기생충 감염에 의해 발생하는 심각한 질환으로, 전형적으로는 팔과 다리 피부의 현저한 종창과 비후를 초래합니다. 상피병 환자의 증가는 비위생, 대량약제 투여(MDA)의 결여, 불충분한 벡터 컨트롤, 치료에 대한 접근 제한 등의 요인에 의한 것이 큽니다. 필라리아증 치료는 근본적인 기생충 감염을 표적으로 하여 염증을 억제하고 림프 손상을 방지함으로써 상피병의 발병 위험을 낮추고 그 심각한 증상을 완화합니다. 예를 들면, 2024년 11월, 세계보건기구(WHO)는, 2023년에도 39개국에 걸쳐 6억 5,700만 명 이상이 림프계 필라리아증의 위험에 노출었으며, 감염을 막기 위한 예방 치료가 필요하다고 보고했습니다. 이처럼 상피병 유병률의 증가가 필라리아증 치료 시장의 성장에 박차를 가하고 있습니다.

의료 시설의 개선도 필라리아증 치료 시장의 성장에 기여할 것으로 예측됩니다. 병원, 진료소, 진단 센터 등의 헬스케어 시설은 환자에게 필수불가결한 의료와 서비스를 제공하고 있습니다. 이러한 헬스케어 시설은, 의료 인프라에 대한 투자 증가, 환자 중심의 케어에 대한 주력, 인구 증가, 고령화 등의 요인에 의해서 개선되고 있습니다. 헬스케어 시설의 충실화로 고도의 진단 도구, 효과적인 약제, 숙련된 의료 전문가에 대한 접근이 확보됩니다. 이를 통해 광범위한 스크리닝, 시기적절한 치료, 지속적인 케어가 촉진되어 환자의 전귀가 향상되고 필라리아증의 부담이 줄어듭니다. 예를 들면, 2023년 5월에 미국 의료 협회가 발표한 미국의 병원수는 6,129로, 전년(6,093)보다 0.591% 증가했습니다. 따라서 헬스케어 시설의 내실화가 필라리아증 치료 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

• 세계의 필라리아증 치료 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
• 최종 이용 산업의 분석
• 세계의 필라리아증 치료 시장 : 성장률 분석
• 세계의 필라리아증 치료 시장 실적 : 규모 및 성장(2019-2024년)
• 세계의 필라리아증 치료 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
• 세계의 필라리아증 치료 전체 시장 규모(TAM)

제6장 시장 세분화

• 세계의 필라리아증 치료 시장 : 약제 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 디에틸카르바마진
• 이버 멕틴
• 알벤다졸
• 기타 약물의 유형
• 세계의 필라리아증 치료 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 약
• 수술
• 기타 치료의 유형
• 세계의 필라리아증 치료 시장 : 유통 채널별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타 유통 채널
• 세계의 필라리아증 치료 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 병원
• 클리닉
• 외래수술센터(ASC)
• 기타 최종 사용자
• 세계의 필라리아증 치료 시장 : 디에틸카르바마진 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 단제요법
• 병용 요법
• 세계의 필라리아증 치료 시장 : 이버멕틴 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 단회투여요법
• 집단의약품관리국(MDA)
• 세계의 필라리아증 치료 시장 : 알벤다졸 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 단독 치료
• 다른 구충약과의 병용
• 세계의 필라리아증 치료 시장 : 기타 약제 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 독시사이클린 요법
• 항히스타민제 및 항염증제

제7장 지역별 및 국가별 분석

• 세계의 필라리아증 치료 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
• 세계의 필라리아증 치료 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

• 필라리아증 치료 시장 : 경쟁 구도
• 필라리아증 치료 시장 : 기업 프로파일
  • Pfizer Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
  • GlaxoSmithKline plc 개요, 제품 및 서비스, 전략 및 재무 분석
  • Teva Pharmaceutical Industries Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석
  • Eisai Co. Ltd. 개요, 제품 및 서비스, 전략 및 재무 분석

제31장 기타 주요 기업 및 혁신 기업

• Dr. Reddy's Laboratories
• Rakshit Drugs
• AdvaCare Pharma
• Orex Pharma Pvt. Ltd.
• Sms Lifesciences
• Enomark Pharma
• Angle Bio Pharma
• Senores Pharmaceuticals Inc.
• Atom pharma
• Devlife Corporation Private Limited
• Orion Life Science
• Heer Pharma Private Limited
• AMGIS Lifescience Ltd.
• Cerata Pharmaceuticals
• Ben Pharmaceuticals

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

• 필라리아증 치료 시장(2029년) : 새로운 기회를 제공하는 국가
• 필라리아증 치료 시장(2029년) : 새로운 기회를 제공하는 부문
• 필라리아증 치료 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제36장 부록

AJY

영문 목차

영문목차

Filariasis treatment involves medical interventions aimed at managing and eliminating infections caused by filarial parasites, which are transmitted through mosquito bites. The goal of treatment is to eradicate the infection, relieve symptoms, and prevent severe complications such as lymphedema (elephantiasis) and blindness.

The main drugs used for filariasis treatment include diethylcarbamazine (DEC), ivermectin, albendazole, and others. Diethylcarbamazine is an antiparasitic medication that targets lymphatic filariasis by eliminating microfilariae and certain adult worms. The treatment options include medication, surgery, and other approaches. These treatments are distributed through various channels, such as hospital pharmacies, retail pharmacies, online pharmacies, and more. They are utilized by a range of end-users, including hospitals, clinics, ambulatory surgical centers, and others.

The filariasis treatment market research report is one of a series of new reports from The Business Research Company that provides filariasis treatment market statistics, including the filariasis treatment industry global market size, regional shares, competitors with the filariasis treatment market share, detailed filariasis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the filariasis treatment industry. This filariasis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The filariasis treatment market size has grown rapidly in recent years. It will grow from $10.26 billion in 2024 to $11.50 billion in 2025 at a compound annual growth rate (CAGR) of 12.1%. The growth during the historic period can be attributed to factors such as the rising incidence of filariasis cases, increased funding, greater investment in research and development, the impact of climate change, and the growth in international travel.

The filariasis treatment market size is expected to see rapid growth in the next few years. It will grow to $17.91 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth during the forecast period can be attributed to factors such as government programs, an increasing focus on healthcare solutions, improvements in healthcare facilities, rising demand for oral drugs, and the continued prevalence of filariasis in endemic regions. Major trends during this period include the introduction of triple-drug therapy, ongoing research to develop longer-acting anti-filarial medications, advancements in CRISPR and molecular biology, the development of new diagnostic tools, and improved techniques for managing lymphedema.

The increasing incidence of elephantiasis is expected to drive the growth of the filariasis treatment market in the coming years. Elephantiasis is a severe condition caused by parasitic infections, leading to significant swelling and thickening of the skin, typically in the arms and legs. The rise in elephantiasis cases is largely due to factors such as poor sanitation, lack of mass drug administration (MDA), inadequate vector control, and limited access to treatment. Filariasis treatment targets the underlying parasitic infection, reducing inflammation and preventing lymphatic damage, which lowers the risk of developing elephantiasis and helps alleviate its severe symptoms. For example, in November 2024, the World Health Organization reported that more than 657 million people across 39 countries were still at risk of lymphatic filariasis in 2023 and needed preventive treatment to stop the transmission of the disease. Thus, the increasing prevalence of elephantiasis is fueling the growth of the filariasis treatment market.

The improvement of healthcare facilities is also expected to contribute to the growth of the filariasis treatment market. Healthcare facilities, including hospitals, clinics, and diagnostic centers, provide essential medical care and services to patients. These facilities are improving due to factors such as increased investment in healthcare infrastructure, a focus on patient-centered care, population growth, and an aging demographic. Better healthcare facilities ensure access to advanced diagnostic tools, effective medications, and skilled healthcare professionals. This promotes widespread screenings, timely treatments, and continuous care, which enhances patient outcomes and reduces the burden of filariasis. For example, in May 2023, the American Health Care Association reported that the United States had 6,129 hospitals, marking a 0.591% increase from the previous year, when there were 6,093 hospitals. Therefore, the improvement of healthcare facilities is driving growth in the filariasis treatment market.

In May 2024, the German Center for Infection Research (DZIF), a Germany-based research institution focused on infectious diseases, partnered with Eisai Co., Ltd., a Japan-based pharmaceutical company, to develop treatments for river blindness and lymphatic filariasis. This collaboration aims to address the needs of affected populations in Africa and tropical regions. Eisai Co., Ltd. is known for providing filariasis treatments, including diethylcarbamazine (DEC) tablets.

Major players in the filariasis treatment market are Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Eisai Co. Ltd., Dr. Reddy's Laboratories, Rakshit Drugs, AdvaCare Pharma, Orex Pharma Pvt. Ltd., Sms Lifesciences, Enomark Pharma, Angle Bio Pharma, Senores Pharmaceuticals Inc., Atom pharma, Devlife Corporation Private Limited, Orion Life Science, Heer Pharma Private Limited, AMGIS Lifescience Ltd., Cerata Pharmaceuticals, Ben Pharmaceuticals, Biofield Pharma Pvt. Ltd.

Asia-Pacific was the largest region in the filariasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in filariasis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the filariasis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The filariasis treatment market consists of revenues earned by entities by providing services such as psychosocial and rehabilitation support, symptom management and supportive care, patient education, and community awareness. The market value includes the value of related goods sold by the service provider or included within the service offering. The filariasis treatment market also includes sales of antiparasitic medications, vector control products, compression garments, topical antibiotics, and antiseptics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Filariasis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on filariasis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for filariasis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The filariasis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Diethylcarbamazine; Ivermectin; Albendazole; Other Drug Types
• 2) By Treatment Type: Medication; Surgery; Other Treatment Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Other End-Users
• Subsegments:
• 1) By Diethylcarbamazine: Monotherapy; Combination Therapy
• 2) By Ivermectin: Single-Dose Therapy; Mass Drug Administration (MDA)
• 3) By Albendazole: Standalone Treatment; Combination With Other Anthelmintics
• 4) By Other Drug Types: Doxycycline Therapy; Antihistamines And Anti-Inflammatory Drugs
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Eisai Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Filariasis Treatment Market Characteristics

3. Filariasis Treatment Market Trends And Strategies

4. Filariasis Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Filariasis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Filariasis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Filariasis Treatment Market Growth Rate Analysis
• 5.4. Global Filariasis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Filariasis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Filariasis Treatment Total Addressable Market (TAM)

6. Filariasis Treatment Market Segmentation

• 6.1. Global Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diethylcarbamazine
• Ivermectin
• Albendazole
• Other Drug Types
• 6.2. Global Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Surgery
• Other Treatment Types
• 6.3. Global Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Filariasis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Other End-Users
• 6.5. Global Filariasis Treatment Market, Sub-Segmentation Of Diethylcarbamazine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monotherapy
• Combination Therapy
• 6.6. Global Filariasis Treatment Market, Sub-Segmentation Of Ivermectin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose Therapy
• Mass Drug Administration (MDA)
• 6.7. Global Filariasis Treatment Market, Sub-Segmentation Of Albendazole, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standalone Treatment
• Combination With Other Anthelmintics
• 6.8. Global Filariasis Treatment Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Doxycycline Therapy
• Antihistamines And Anti-Inflammatory Drugs

7. Filariasis Treatment Market Regional And Country Analysis

• 7.1. Global Filariasis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Filariasis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Filariasis Treatment Market

• 8.1. Asia-Pacific Filariasis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Filariasis Treatment Market

• 9.1. China Filariasis Treatment Market Overview
• 9.2. China Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Filariasis Treatment Market

• 10.1. India Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Filariasis Treatment Market

• 11.1. Japan Filariasis Treatment Market Overview
• 11.2. Japan Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Filariasis Treatment Market

• 12.1. Australia Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Filariasis Treatment Market

• 13.1. Indonesia Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Filariasis Treatment Market

• 14.1. South Korea Filariasis Treatment Market Overview
• 14.2. South Korea Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Filariasis Treatment Market

• 15.1. Western Europe Filariasis Treatment Market Overview
• 15.2. Western Europe Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Filariasis Treatment Market

• 16.1. UK Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Filariasis Treatment Market

• 17.1. Germany Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Filariasis Treatment Market

• 18.1. France Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Filariasis Treatment Market

• 19.1. Italy Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Filariasis Treatment Market

• 20.1. Spain Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Filariasis Treatment Market

• 21.1. Eastern Europe Filariasis Treatment Market Overview
• 21.2. Eastern Europe Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Filariasis Treatment Market

• 22.1. Russia Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Filariasis Treatment Market

• 23.1. North America Filariasis Treatment Market Overview
• 23.2. North America Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Filariasis Treatment Market

• 24.1. USA Filariasis Treatment Market Overview
• 24.2. USA Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Filariasis Treatment Market

• 25.1. Canada Filariasis Treatment Market Overview
• 25.2. Canada Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Filariasis Treatment Market

• 26.1. South America Filariasis Treatment Market Overview
• 26.2. South America Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Filariasis Treatment Market

• 27.1. Brazil Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Filariasis Treatment Market

• 28.1. Middle East Filariasis Treatment Market Overview
• 28.2. Middle East Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Filariasis Treatment Market

• 29.1. Africa Filariasis Treatment Market Overview
• 29.2. Africa Filariasis Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Filariasis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Filariasis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Filariasis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Filariasis Treatment Market Competitive Landscape
• 30.2. Filariasis Treatment Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eisai Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Filariasis Treatment Market Other Major And Innovative Companies

• 31.1. Dr. Reddy's Laboratories
• 31.2. Rakshit Drugs
• 31.3. AdvaCare Pharma
• 31.4. Orex Pharma Pvt. Ltd.
• 31.5. Sms Lifesciences
• 31.6. Enomark Pharma
• 31.7. Angle Bio Pharma
• 31.8. Senores Pharmaceuticals Inc.
• 31.9. Atom pharma
• 31.10. Devlife Corporation Private Limited
• 31.11. Orion Life Science
• 31.12. Heer Pharma Private Limited
• 31.13. AMGIS Lifescience Ltd.
• 31.14. Cerata Pharmaceuticals
• 31.15. Ben Pharmaceuticals

32. Global Filariasis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Filariasis Treatment Market

34. Recent Developments In The Filariasis Treatment Market

35. Filariasis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Filariasis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Filariasis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Filariasis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료